Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 38 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

27%

8 of 30 completed with results

Key Signals

8 with results100% success

Data Visualizations

Phase Distribution

34Total
Not Applicable (3)
Early P 1 (2)
P 1 (26)
P 4 (3)

Trial Status

Completed30
Recruiting4
Unknown3
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 30 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT05044962Not ApplicableRecruiting

Kuwa Free! - Live Free!

NCT07516548Not Yet Recruiting

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

NCT05789173Early Phase 1RecruitingPrimary

Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK

NCT07068841Phase 1Completed

Pharmacokinetic Effect of Y-3 on Repaglinide,Warfarin and Omeprazole in Healthy Participants

NCT04669678Phase 4Completed

Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa

NCT04487145Phase 4CompletedPrimary

Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy

NCT05492318Phase 1CompletedPrimary

Perpetrator DDI Potential of Givinostat as Inhibitor and Inducer of CYP3A and P-gp Activity

NCT06682325RecruitingPrimary

Pharmaco-proteomic Platform to Evaluate Drug Interactions in Liver Transplant Patients

NCT06381375RecruitingPrimary

Drug-drug Interactions With Anti-tuberculous Drugs

NCT06066060Phase 1Completed

A DDI Study of JMKX000623 and Metformin Hydrochloride

NCT05699070Phase 1UnknownPrimary

Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects

NCT05692570Phase 1CompletedPrimary

A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers

NCT05339672UnknownPrimary

Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban

NCT05073627Phase 1Completed

The Effect of Dicloxacillin on Oral Absorption of Drugs

NCT04650542Phase 1CompletedPrimary

Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects

NCT04459598Phase 1Completed

A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants

NCT03530995Phase 1CompletedPrimary

Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers

NCT05306379Phase 1CompletedPrimary

Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin

NCT02174822Phase 1CompletedPrimary

A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects

NCT05108051Phase 1CompletedPrimary

Study to Investigate the Potential Drug-Drug Interaction Between ZSP1273 and Oseltamivir

Scroll to load more

Research Network

Activity Timeline